DIA

DIA issues guide to improve computerized clinical trial data

Wednesday, August 17, 2011 10:36 AM

The rapid uptake and incorporation of computerized systems and electronic data management into clinical research needs to be backed up by sound validation processes to ensure data quality and integrity are not compromised, says the Drug Information Association (DIA), according to PharmaTimes.

More... »

New Worldwide Executive Director Shares DIA’s Vision at EuroMeeting

Tuesday, March 30, 2010 06:56 AM

With a new worldwide executive director and vision, the Drug Information Association (DIA) has grand plans for 2010 and beyond.

More... »

DIA Offers Clinical Safety and Pharmacovigilance Certification

Wednesday, December 30, 2009 07:21 AM

The Drug Information Association (DIA) recently launched its Clinical Safety and Pharmacovigilance Certificate Program—the organization’s third certificate program for clinical research professionals.

More... »

DIA Appoints New Worldwide Executive Director

Thursday, September 10, 2009 06:27 AM

The Drug Information Association (DIA) appointed Paul Pomerantz as its new worldwide executive director, replacing William Brassington who has served as acting executive director since July 2008.

More... »

PMDA’s New Five-Year Plan Under Way Today

Wednesday, April 1, 2009 08:00 AM

Japan’s regulatory authority, Pharmaceuticals and Medical Devices Agency (PMDA), is launching several new initiatives in fiscal year 2009, which begins today. PMDA representatives were out in force at the DIA EuroMeeting in Berlin last week to explain the new programs, which will be implemented between fiscal year 2009 and fiscal year 2013.

More... »

DIA Opens Beijing Office

Wednesday, November 19, 2008 11:13 AM

The Drug Information Association (DIA) has expanded its worldwide operations by opening an office in Beijing, China. Headquartered in Horsham, Pa., DIA has regional offices in Switzerland, Japan, and now China.

More... »

McGoldrick Leaves DIA, Brassington Named Acting Executive Director

Wednesday, August 6, 2008 08:01 AM

Linda McGoldrick, appointed executive director of the Drug Information Association (DIA) earlier this year, has left her position, according to a release on the DIA’s web site.

More... »

Is India Ready For Phase I Studies?

Tuesday, August 15, 2006 08:32 AM

India has come a long way as a center for clinical drug trials, but is the country ready for Phase I studies? I think the short answer - and others would agree - is “no”. Take, for instance, recent comments by Ashwini Kumar, the Drug Controller General of India (DCGI), who spoke recently at the Drug Information Association’s (DIA) Annual Meeting in Philadelphia. Kumar, head of the Central Drug Standard Control Organization (CDSCO), India’s regulatory agency, said that India needed to create an environment for the best quality assurance before embarking on phase I studies...

More... »

Top Stories for the Week of August 7th, 2006

Monday, August 7, 2006 09:05 AM

Top News

More... »

CenterWatch’s 42nd Annual DIA Round Up

Monday, June 26, 2006 10:57 AM

This year’s Drug Information Association (DIA) 42nd annual industry conference, held in Philadelphia, Penn attracted nearly 10,000 attendees from across every sector in the drug development industry. Presenting at the show were over 400 U.S. and close to 200 international companies, from both developed markets and emerging regions around the globe. Nearly 1,000 delegates from 50 countries were scheduled to attend.

More... »